Telehealth-Filter Ventilation ( COMET2P1 )

NCT ID: NCT04969783

Last Updated: 2025-05-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

164 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-26

Study Completion Date

2024-03-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goals of this project are to determine the effects of varying degrees of cigarette filter ventilation on biomarkers of toxicant exposure and smoking behavior and on subjective responses to the cigarette.

The primary aim of this study is to examine the effects of unventilated vs ventilated filter cigarettes on urinary biomarkers of toxicant exposure and smoking behavior (e.g., cigarettes per day, intensity of smoking). The secondary objectives are 1) to examine the effects of cigarette filter ventilation on subjective measures such as cigarette dependence and responses to study cigarettes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This randomized controlled multi-site study will assess the effect of cigarettes with unventilated vs. ventilated filters on smoking behavior and biomarkers of tobacco toxicant exposure. The study, using telehealth and brief visits, will also examine the feasibility of remote collection of multiple biological samples.

Subjects (N=164; N=82 in each group) will be randomly assigned to: 1) Ventilated cigarettes; or 2) Unventilated cigarettes. Smokers will undergo an in person screening and then a 9 week experimental trial; 1 week of usual brand cigarettes; 2 weeks of ventilated study cigarettes and 6 weeks on either the ventilated or unventilated study cigarettes.

Subjective measures, alveolar carbon monoxide, blood pressure and cigarettes per day will be collected remotely. Biological samples collected at home will be dropped off at the clinic where the study cigarettes will be dispensed.

Biomarker samples will be assessed for total nicotine equivalents, tobacco specific nitrosamines and volatile organic compound.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Phase III randomized, single blind, multi-center study assessing the impact of filter ventilation
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants
Single blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ventilated Cigarette Filter

Filters with approximately 24-32% filter ventilation

Group Type EXPERIMENTAL

Ventilated Cigarette Filter

Intervention Type OTHER

Ventilated Cigarette Filter

Unventilated Cigarette Filter

Filters with approximately 0-5.0% filter ventilation

Group Type EXPERIMENTAL

Unventilated Cigarette Filter

Intervention Type OTHER

Unventilated Cigarette Filter

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ventilated Cigarette Filter

Ventilated Cigarette Filter

Intervention Type OTHER

Unventilated Cigarette Filter

Unventilated Cigarette Filter

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 21 years of age
* Biochemically confirmed regular cigarette smoker
* Daily smoker, 5-30 cigarettes per day.
* Usual brand cigarettes 16-36% ventilation

Exclusion Criteria

* Unstable health
* Unstable medications
* Pregnant or nursing
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ohio State University

OTHER

Sponsor Role collaborator

Masonic Cancer Center, University of Minnesota

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dorothy K Hatsukami, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Masonic Cancer Center, University of Minnesota

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Minnesota Tobacco Research Program

Minneapolis, Minnesota, United States

Site Status

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P01CA217806-S2

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

P01CA217806

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2021LS034

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PeRiopEratiVE SmokiNg CessaTion Trial
NCT05102123 ACTIVE_NOT_RECRUITING PHASE3
Proactive Outreach for Smoking Treatment
NCT04988477 COMPLETED PHASE2
Connect to Quit for Smoking
NCT01299896 COMPLETED NA